%0 Journal Article
%T New government drug repurposing programs: Opportunities and uncertainties.
%A Liddicoat J
%A Hamidzadeh A
%A Liddell K
%A Schito M
%A Simon D
%A Aboy M
%A Minssen T
%J Sci Transl Med
%V 16
%N 753
%D 2024 Jun 26
%M 38924430
%F 19.319
%R 10.1126/scitranslmed.adl0998
%X Drug repurposing can be cheaper and faster than developing new compounds. Yet, it remains underused, partially because of regulatory and intellectual property challenges. Policy-makers in the United States and Europe have created seven drug development programs that aim to overcome these challenges using a variety of different strategies.